Kyntra Bio, Inc. (KYNB)

NASDAQ

$6,13

$-0,06

(-0,97%)

Regular Market

Kyntra Bio, Inc. (KYNB) Live Price Chart

Last updated: ⁦2026-10-13 13:45:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Kyntra Bio, Inc. (KYNB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6,13, with a market capitalisation of $24,74M and a P/E ratio of 0,14. Over the past 52 weeks, its price has ranged from $5,62 to $9,70. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$24,74M
Open	$6,19
Day's High	$9,70
Day's Low	$5,62
Previous Close	$6,12
Volume	1,82K
Average Volume	18,31K
P/E Ratio	0,14
52-Week High	$9,70
52-Week Low	$5,62
Dividend Yield	--
Earnings Date	--

Kyntra Bio, Inc. (KYNB) Stock Price Today

Kyntra Bio, Inc. (KYNB) is currently trading at $6,13 as of 2026-10-13 13:43:00, up 0,11% ($0,01) from the previous close of $6,12

During today's regular trading session, KYNB has traded between $5,62 and $9,70, with a trading volume of 1,82K shares. The current price is near the lower end of today's range.

Kyntra Bio, Inc. (KYNB) 7-Day Stock Price Change

Over the past seven days, Kyntra Bio, Inc. (KYNB) moved from $6,31 to $6,13, representing a decline of 2,90% ($0,18).

The stock traded between $5,62 and $6,64 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 27,21 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

KYNB 52-Week Price Position

Position in Range: 12,4%

52W Low$5,62

52W High$9,70

KYNB is currently trading at $6,13, placing it 12,4% of the way from its 52-week low of $5,62 to its 52-week high of $9,70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kyntra Bio, Inc. (KYNB)?

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Kyntra Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	34
Exchange	NASDAQ
Company Website	https://www.kyntrabio.com

How to Buy Kyntra Bio, Inc. (KYNB) Stock on MEXC

Eligible investors can buy real shares of Kyntra Bio, Inc. (KYNB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KYNB and Place Your Order

Open the RealStocks trading page and search for KYNB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kyntra Bio, Inc. (KYNB) stock price today?

Kyntra Bio, Inc. (KYNB) is currently trading at $ 6,13, up 0,11% ($0,01) from the previous close of $ 6,12. Intraday prices update in real time during regular trading hours.

2.Is KYNB stock going up or down today?

As of 2026-10-13 13:43:00, KYNB is trading at $ 6,13, up 0,11% ($0,01) from its previous close of $ 6,12. The stock has traded between $ 5,62 and $ 9,70 during today’s regular session. Past price movements do not guarantee future results.

3.What is KYNB pre-market price?

As of 2026-10-13 13:43:00, KYNB is trading at $ 6,18 in pre-market trading, up 1,05% ($0,06) from the previous close of $ 6,12. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KYNB after-hours price?

As of 2026-10-13 13:43:00, KYNB is trading at $ 6,15 in after-hours trading, up 0,41% ($0,02) from the regular-session close of $ 6,12. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KYNB stock trading now?

KYNB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KYNB sit relative to its 52-week high and low?

Over the past 52 weeks, KYNB has traded between a low of $ 5,62 and a high of $ 9,70. At $ 6,13, the stock is positioned 12,4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kyntra Bio, Inc. in?

Kyntra Bio, Inc. (KYNB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kyntra Bio, Inc.'s market capitalisation and where is it listed?

Kyntra Bio, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 24,74M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KYNB valued in terms of P/E ratio and EPS?

KYNB trades at a P/E ratio of 0,14, based on trailing-twelve-month EPS of $ 45,24. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kyntra Bio, Inc. pay a dividend?

Kyntra Bio, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.